Nevada § 689A.0423 Coverage for treatment of certain inherited metabolic diseases required

Nevada Statutes

§ 689A.0423 — Coverage for treatment of certain inherited metabolic diseases required

Nevada § 689A.0423

Title 57INSURANCE

Ch. 689AIndividual

REQUIRED PROVISIONS

This text of Nevada § 689A.0423 (Coverage for treatment of certain inherited metabolic diseases required) is published on Counsel Stack Legal Research, covering Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Nev. Rev. Stat. § 689A.0423 (2026).

Text

1. A policy of health insurance must provide coverage for:

(a)Enteral formulas for use at home that are prescribed or ordered by a physician as medically necessary for the treatment of inherited metabolic diseases characterized by deficient metabolism, or malabsorption originating from congenital defects or defects arising shortly after birth, of amino acid, organic acid, carbohydrate or fat; and

(b)At least $2,500 per year for special food products which are prescribed or ordered by a physician as medically necessary for the treatment of a person described in paragraph (a). 2. The coverage required by subsection 1 must be provided whether or not the condition existed when the policy was purchased. 3. A policy subject to the provisions of this chapter that is delivered, issued for delive

Free access — add to your briefcase to read the full text and ask questions with AI

1. A policy of health insurance must provide coverage for:
(a) Enteral formulas for use at home that are prescribed or ordered by a physician as medically necessary for the treatment of inherited metabolic diseases characterized by deficient metabolism, or malabsorption originating from congenital defects or defects arising shortly after birth, of amino acid, organic acid, carbohydrate or fat; and
(b) At least $2,500 per year for special food products which are prescribed or ordered by a physician as medically necessary for the treatment of a person described in paragraph (a).
2. The coverage required by subsection 1 must be provided whether or not the condition existed when the policy was purchased.
3. A policy subject to the provisions of this chapter that is delivered, issued for delivery or renewed on or after July 1, 2021, has the legal effect of including the coverage required by this section, and any provision of the policy or the renewal which is in conflict with this section is void.
4. As used in this section:
(a) “Enteral formula” includes, without limitation, a formula that is ingested orally.
(b) “Inherited metabolic disease” means a disease caused by an inherited abnormality of the body chemistry of a person.
(c) “Special food product” means a food product that is specially formulated to have less than one gram of protein per serving and is intended to be consumed under the direction of a physician for the dietary treatment of an inherited metabolic disease. The term does not include a food that is naturally low in protein.